Improving Lives Through Innovation

The Power of Human Keratin

ProgenaMatrix is an active wound matrix manufactured from human keratin and numerous other proteins. Immediately upon application, ProgenaMatrix creates a barrier to maintain an environment important for the healing process – with no delay. The unique characteristics of ProgenaMatrix make it a biocompatible primary wound matrix and protective barrier; it is intended for use in dry, light, and moderately exuding partial and full-thickness wounds.

Science for Patient-Centric Solutions

The Importance of Human Keratin

Until recently, keratin has long been considered to have the singular function of providing structure to cells and tissue. Now, Cell Constructs has identified another important function for human keratin – an active wound matrix. It’s estimated that 14 million people suffer from chronic wounds annually. Complications from chronic wounds can lead to debilitating and life-threatening complications as well as increased healthcare costs.1

1. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367-7.

How ProgenaMatrix Works

The unique characteristics of ProgenaMatrix make it a biocompatible primary wound matrix and protective barrier. ProgenaMatrix is engineered to be transparent, allowing for wound visualization during treatment. ProgenaMatrix is packaged fully hydrated and capable of maintaining moisture in the wound bed. As healing progresses and wound margins shrink, ProgenaMatrix is designed to lift up and away as tissue heals, which can reduce the risk of maceration by limiting contact with the peri-wound tissue.1

1. Mikel G, Weir D. Prevention and Treatment of Moisture-Associated Skin Damage (Maceration) in the Periwound Skin. Journal of Wound, Ostomy, and Continence Nursing. 2007; 34, 2: 153-157.

Learn more about ProgenaMatrix™ wound dressing and the science of healing.

Improving Wound Care through Innovation

The unique characteristics of ProgenaMatrix make it a biocompatible primary wound matrix and protective barrier.

Proprietary Technology

Human Keratin Biomaterial

Cell Constructs uses pure human keratin selectively extracted from hair as a starting material to construct sterile implants and matrices. This technology is covered by a recently issued United States Patent (US 9,072,818). Other patents are pending.

News & Events

Latest News

Cell Constructs submits for 510(k)
Cell Constructs has submitted for 510(k) and we are awaiting FDA approval ...
Read More
/ News
Cell Constructs launches new website
Cell Constructs is excited to announce the official launch of our new website! Check it out! Don't forget to follow ...
Read More
/ News
New corporate and manufacturing facility
Cell Constructs announces the opening of their new corporate and manufacturing facility in Marietta, GA ...
Read More
/ News

Upcoming Events

Symposium on Advanced Wound Care

Start date: April 25, 2018

End date: April 29, 2018

Location: Charlotte, NC

EWMA European Wound Management Association – EWMA 2018 Annual Conference

Start date: May 9, 2018

End date: May 11, 2018

Location: Krakow, Poland

Connect with Us

ProgenaMatrix is currently undergoing a 510k premarket review by FDA for dry, light and moderately exuding partial and full thickness wounds. Not available for sale or other clinical use.

Copyright ©2017, Cell Constructs, LLC. All rights reserved.